A survey of nonxanthine derivatives as adenosine receptor ligands

Nucleosides and Nucleotides

Volumn 15, Issue 1-3, 1996, Pages 693-717

  Siddiqi, Suhaib M ^a   Ji, Xiao Duo ^a   Melman, Neli ^a   Olah, Mark E ^b   Jain, Rahul ^a   Evans, Patricia ^a   Glashofer, Marc ^a   Padgett, William L ^a   Cohen, Louis A ^a   Daly, John W ^a   Stiles, Gary L ^b   Jacobson, Kenneth A ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 (5 ISOQUINOLINESULFONYL) 2 METHYLPIPERAZINE; 4 (3 TERT BUTYLAMINO 2 HYDROXYPROPOXY) 2 BENZIMIDAZOLONE; 6 CYANO 7 NITRO 2,3 QUINOXALINEDIONE; ADENOSINE RECEPTOR; AMFORRELIC ACID; BENZIMIDAZOLE DERIVATIVE; CALCIMYCIN; CARBOLINE DERIVATIVE; CHLOROTHIAZIDE; CHLORZOXAZONE; CROMOGLYCATE DISODIUM; CYTOCHALASIN A; DIHYDROFOLIC ACID; DIPYRIDAMOLE; ESCULIN; FASUDIL; FOLIC ACID; HESPERIDIN; IMIDAZO[1,5 C]PYRIMIDINE DERIVATIVE; INDOLE DERIVATIVE; LODOXAMIDE; NEOPTERIN; PROADIFEN; PYRAZOLE DERIVATIVE; PYRAZOLO[3,4 B]PYRIDINE DERIVATIVE; PYRIDAZINE DERIVATIVE; PYRIDINE DERIVATIVE; PYRIMIDINE DERIVATIVE; PYRROLE DERIVATIVE; RECEPTOR SUBTYPE; SULMAZOLE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANIMAL TISSUE; ARTICLE; BRAIN; CHO CELL; CONTROLLED STUDY; DRUG RECEPTOR BINDING; NONHUMAN; RAT; STRUCTURE ACTIVITY RELATION;

EID: 9044247854     PISSN: 07328311     EISSN: None     Source Type: Journal    
DOI: 10.1080/07328319608002416     Document Type: Article

References (40)

1. van Galen, P. J. M.; Stiles, G. L.; Michaels, G.; Jacobson, K. A. Med. Res. Rev. 1992, 12, 423-471.
2. M. Jacobson, in Adenosine and Adenine Nucleotides: From Molecular Biology to Integrative Physiology, eds. L. Bellardinelli, A. Pelleg, Kluwer, Boston, 1995, 5-13.
3. Lasley, R.D.; Bünger, R.; Mentzer, R.M., in Adenosine and Adenine Nucleotides: From Molecular Biology to Integrative Physiology, eds. L. Bellardinelli, A. Pelleg, Kluwer, Boston, 1995, 351-360.
4. Rudolphi, K.A.; Schubert, P., in Adenosine and Adenine Nucleotides: From Molecular Biology to Integrative Physiology, eds. L. Bellardinelli, A. Pelleg, Kluwer, Boston, 1995, 391-397.
5. Beaven, M. A., Ramkumar, V., Ali, H. Trends Pharmacol. Sci. 1994, 15:13-14.
6. Ramkumar, V.; Stiles, G.L.; Beaven, M.A.; Ali, H. J. Biol. Chem. 1993, 268, 16871-16890.
7. Carruthers, A. M.; Fozard, J. Eur J. Pharmacol. 1993, 250, 185-188.
8. Daly, J. W.; Hong, O.; Padgett, W. L.; Shamim, M. T.; Jacobson, K. A.; Ukena, D. Biochem. Pharmacol. 1988, 37, 655-664.
9. Zhou, Q. Y.; Li, C. Y.; Olah, M. E.; Johnson, R. A.; Stiles, G. L.; Civelli, O. Proc. Natl. Acad. Sci. U.S.A. 1992, 89, 7432-7436.
10. Gallo-Rodriguez, C.; Ji, X. D.; Melman, N.; Siegman, B. D.; Sanders, L. H.; Orlina, J.; Fischer, B.; Pu, Q. L.; Olah, M. E.; van Galen, P. J. M.; Stiles, G. L.; Jacobson, K. A. J. Med. Chem. 1994, 37, 636-646.
11. von Lubitz, D. K. J. E.; Lin, R. C. S.; Popik, P.; Carter, M. F.; Jacobson, K. A. Eur. J. Pharmacol. 1994, 263, 59-67.
12. Daly, J. W.; Hutchinson, K. D.; Secunda, S. I.; Shi, D.; Padgett, W. L.; Shamin, M. T. Med. Chem. Res. 1994, 4, 293-306
13. Jain, R.; Cohen, L.A., manuscript in preparation.
14. Davies, L. P.; Baird, L. J.; Hall, J. G. Neuropharmacology 1987, 26, 493-7.
15. Hidaka, H.; Inagaki, M.; Kawamoto, S. Sasaki, Y. Biochemistry, 1984, 23, 5036-5041.
16. Ewing, A. G.; Bigelow, J. C.; Wightman, R. M. Science, 1983, 221, 169.
17. Yahara, I.; Harada, F.; Sekita, S.; Yoshihira, K.; Natori, S. J. Cell. Biol. 1982, 92, 69-78.
18. Croucher, M.; DeSarro, G.; Jensen, L. Meldrow, B. Eur. J. Pharmacol., 1984, 104, 55-60.
19. Klitgaard, H.; Knutsen, L. J. S.; Thomsen, C. Eur. J. Pharmacol. 1993, 242, 221-228.
20. Schneller, S. W.; Ibay, A. C.; Christ, W. J.; Bruns, R. F. J. Med. Chem. 1989, 32, 2247- 2254.
21. Leonard, N. J.; Morrice, A. G.; Sprecker, M. A., J. Org. Chem. 1975, 40, 356-363.
22. Witkop, B.; Patrick, J. B. J. Am. Chem. Soc. 1950, 73, 2196-2200.
23. Christensen, H. N. Nutr. Rev. 1993, 51, 149-150.
24. Bruns, R. F.; Fergus, J. H. Mol. Pharmacol. 1990, 35, 939-949.
25. Elonen, E.; Mattila, M. J.; Saarnivaara, L. Eur. J. Pharmacol. 1974, 1, 178-88.
26. Lohse, M. J.; Klotz, K. N.; Jakobs, K. H.; Schwabe, U. J. Neurochem. 1985, 45, 1761-1770.
27. Kim, H. O.; Ji, X. D.; Melman, N.; Olah, M. E.; Stiles, G. L.; Jacobson, K. A. J. Med.Chem. 1994, 37, 4020-4030.
28. van Galen, P. J. M.; van Bergen, A. H.; Gallo-Rodriquez, C.; Melman, N.; Olah, M. E.; IJzerman, A. P.; Stiles, G. L.; Jacobson, K. A. Mol. Pharmacol. 1994, 45, 1101-1111.
29. Olah, M. E.; Gallo-Rodriguez, C.; Jacobson, K. A.; Stiles, G. L. Mol. Pharmacol. 1994, 45, 978-982.
30. Cheng, Y. C.; Prusoff, W. H. Biochem. Pharmacol. 1973, 22, 3099-3108.
31. Schwabe, U.; Trost, T. Naunyn-Schmiedeberg's Arch. Pharmacol. 1980, 313, 179-187.
32. Jarvis, M. F.; Schulz, R.; Hutchison, A. J.; Do, U. H.; Sills, M. A.; Williams, M. J Pharmacol Exp Ther 1989, 251, 888-93.
33. Müller, C. E.; Hide, I.; Daly, J. W.; Rothenhausler, K.; Eger, K. J. Med. Chem. 1990, 33, 2822-2828.
34. Glennon, R. A.; Tejani-Butt, S. M.; Padgett, W.; Daly, J. W. J. Med. Chem. 1984, 27, 1364-1367.
35. Peet, N. P.; Dickerson, G. A.; Abdallah, A. H.; Daly, J. W.; Ukena, D. J. Med. Chem. 1988, 31, 2034-2039.
36. Peet, N. P.; Malecha, J.; LeTourneau, M. E.; Sunder, S. J. Heterocyclic Chem. 1989, 26, 257-264
37. Abdallah, A.; Burnell, J. W.; Cregge, R. J. Drug Devel. Res., 1986, 7, 185-193.
38. Macko, E.; Weisbach, J.A.; Douglas, B. Arch. Int. Pharmacodyn. Ther. 1972, 198, 145-161.
39. Jacobson, K.A.; Siddiqi, S.M.; Olah, M.E.; Ji, X.d.; Melman, N.; Bellamkonda, K., Meshulam, Y.; Stiles, G.L.; and Kim, H.O. J. Med. Chem., 1995, 38, 1720-1735.
40. Brackett, L. E.; Daly, J. W. Biochem. Pharmacol. 1994, 47, 801-814.